Understanding the Value of Total Shoulder Arthroplasties at Physician-Owned Hospitals

Azeem Tariq Malik1, Mathangi J Sridharan, Julie Y Bishop

  • 1From the Department of Orthopaedics, The Ohio State University Wexner Medical Center, Columbus, OH.

Insights

Total shoulder arthroplasties (TSAs) at physician-owned hospitals (POHs) show similar clinical outcomes to non-POHs, except for higher stiffness rates. However, TSAs at POHs demonstrate significantly lower costs, warranting further value assessment.

Area of Science:

  • Orthopedic Surgery
  • Health Services Research
  • Healthcare Economics

Background:

  • Physician-owned hospitals (POHs) face scrutiny over cost, quality, and patient selection.
  • The Affordable Care Act restricted new POH formation.
  • Rising utilization of total shoulder arthroplasties (TSAs) necessitates evaluating TSA quality and cost at POHs.

Purpose of the Study:

  • To compare the quality and cost of TSAs performed at POHs versus non-POHs.
  • To assess patient outcomes and healthcare charges associated with TSAs in different hospital types.

Main Methods:

  • Analysis of Medicare 100% Standard Analytical Files (2011-2014).
  • Inclusion of patients undergoing anatomic or reverse TSA at POHs and non-POHs.
  • Multivariate regression analyses to compare 90-day and 1-year outcomes and costs.

Main Results:

  • No significant differences in major complications (infections, dislocations, fractures, PE, DVT, AMI, sepsis) between POHs and non-POHs.
  • Higher odds of postoperative stiffness at 90 days (OR 1.39) and 1 year (OR 1.51) for TSAs at POHs.
  • Significantly lower risk-adjusted 90-day charges (-$8,904) and costs (-$1,659) for TSAs at POHs.

Conclusions:

  • TSAs at POHs yield comparable clinical outcomes to non-POHs, with slightly increased stiffness.
  • POHs demonstrate lower healthcare costs for TSAs.
  • Further research is recommended to evaluate the overall value of care provided by POHs for TSAs.
Abstract

Related Concept Videos